×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Costing Strategies for Sustainable Drug Development
Session Chair(s)
Stella Stergiopoulos, MPH, MS
Director, Health Economic and Outcomes Research
EQRx, United States
Under Which Network Conditions Does Outsourcing to a CRO Reduce Clinical Trial Costs?
Learning Objective : Characterize critical steps in clinical study planning; Glean best budget planning and forecasting practices; Describe how to optimize partnership networks to decrease clinical trial costs and increase overall value of retaining clinical trial partners; Discuss how to apply an analytical framework for estimating sponsor outsourcing costs; Provide a directional benchmark on partner/vendor selection process costs.
Speaker(s)
Benchmarking the Clinical Budget and Outsourcing Processes
Stella Stergiopoulos, MPH, MS
EQRx, United States
Director, Health Economic and Outcomes Research
Under Which Network Conditions Does Outsourcing to a CRO Reduce Clinical Trial Costs?
Erika Buonansegna, MSc
Technical University of Denmark, Denmark
PhD Student
Tracking Cost Savings During Transformational Change: A Focus on Risk-Based Monitoring
Kyle Given
Medidata Solutions Worldwide, United States
Principal, Strategic Consulting Services
Have an account?